NEW YORK, Sept. 8 (GenomeWeb News) - Genstruct, a biological mechanism discovery company, said today that it has raised $6.5 million in a round of Series A financing.

Proceeds of the financing, the Cambridge, Mass.-based company said, will be used to expand its technical and business teams, build intellectual property around the company's enabling technology, and conduct internal discovery programs.

The financing was led by A. M. Pappas and Associates, which has placed managing partner Art Pappas on Genstruct's board, and Flagship Ventures.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.